Loading
OneMedNet Corp Stock: price and insider trades · United States
2 insiders bought €1.8M of shares over the last 90 days, the latest by Kosasa Thomas, filed 13 Oct 2026.
Cluster: 2 buyers in 30 daysOneMedNet Corp: what insiders have been doing
Every trade that managers of OneMedNet Corp disclose to SEC (Form 4) is tracked on this page. The company sits in the Health Care sector. In the past year (23 October 2025 to 23 October 2026), 125 filings came from 9 insiders.
The record shows 82 purchases on the open market worth €4.9M, made by 5 insiders, against 7 sales worth €278k by 2 insiders. Taken together, the purchases exceed the sales by €4.7M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The largest single trade was a purchase of €873k by Kosasa Thomas, published on 7 August 2026, equal to 2.6% of the market capitalisation. Those buying include 3 senior executives, 1 finance chief and 1 chief executive.
In the case of 27 purchases, another manager of the company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The clock since the last published purchase (13 October 2026) now reads 11 days.
With 125 filings in twelve months, the company is more active than the median of 24 filings across the 3,167 companies we follow on the same exchange. The full history, which starts in 2023, counts 82 purchases against 8 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 1.4 m USD and net income at -2.8 m USD.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
127
Thresholds
n/a
Buy Volume
€5M
82 ops. · all time
Sell Volume
€1M
8 ops. · all time
Who traded when
BuySaleJeffrey Yu22 buys
Thomas Kosasa9 buys
Aaron Green1 buy4 sales
Eric Casaburi3 buys
Robert Lawrence Golden3 sales
Since the insiders bought
- -30.7%Entry US$6.51 · Close 16 Oct 2026 US$4.51
- +3.9%Entry US$0.66 · Close at T+30 US$0.69
- +12.0%Entry US$5.85 · Close at T+90 US$6.55
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$4.75
Analyst consensus
Income statement
RevenueUS$1.4M
Gross profit-US$503k-37% margin
EBITDA-US$2.7M-196% margin
Net income-US$2.8M-206.1% margin
Valuation
Beta1.15
Balance sheet & cash
Market capUS$27.7M
Total debtUS$570k
Free Cash Flow-US$7.5M
Profitability & ownership
ROA-342.1%
% insiders72.1%
% institutions29.9%
Last declaration on 13 October 2026
Declarations127 total
129,758 shares@ US$5.782.98% mcap30.6% of flowCommon StockSEC:0001493152-26-046909:0
Canonical exit: 5 Jan 2027 (T+90)
45,126 shares@ US$5.541.00% mcap14.1% of flowCommon StockSEC:0001493152-26-046908:0
Canonical exit: 7 Jan 2027 (T+90)
10,000 shares0Common StockSEC:0001493152-26-046648:0
35,000 shares0Common StockSEC:0001493152-26-046648:1
2,500 shares@ US$6.600.056% mcap29.7% of flowCommon StockSEC:0001493152-26-046648:2
3,000 shares@ US$6.300.064% mcap34.2% of flowCommon StockSEC:0001493152-26-046648:3
3,000 shares@ US$6.630.068% mcap36.1% of flowCommon StockSEC:0001493152-26-046648:4
65,000 shares0Common StockSEC:0001493152-26-046652:0
5,000 shares@ US$7.3920.13% mcap19.4% of flowCommon StockSEC:0001493152-26-046652:1
1,667 shares@ US$6.480.037% mcap5.7% of flowCommon StockSEC:0001493152-26-046652:2
142,857 shares@ US$0.630.33% mcap4.9% of flowCommon StockSEC:0001493152-26-042642:0
Canonical exit: 9 Dec 2026 (T+90)
1,449,275 shares@ US$0.692.58% mcap57.7% of flowCommon StockSEC:0001493152-26-036660:0
Canonical exit: 28 Oct 2026 (T+90)
36,650 shares@ US$0.573310.0% of flowCommon StockSEC:0001493152-26-029880:0
Canonical exit: 21 Sept 2026 (T+90)
595,238 shares@ US$0.8428.1% of flowCommon StockSEC:0001493152-26-018860:0
Canonical exit: 7 May 2026 (T+90)
903,614 shares@ US$0.8347.7% of flowCommon StockSEC:0001493152-26-018861:0
Canonical exit: 30 Jun 2026 (T+90)
219,429 shares@ US$0.8311.6% of flowCommon StockSEC:0001493152-26-018861:1
280,898 shares@ US$0.890.61% mcap14.2% of flowCommon StockSEC:0001493152-26-018860:1
Canonical exit: 22 Jul 2026 (T+90)
61,555 shares@ US$1.2013.1% of flowCommon StockSEC:0001493152-25-029137:1
64,767 shares@ US$2.2345100.0% of flowCommon StockSEC:0001493152-25-029137:0
47,000 shares@ US$0.48640.3% of flowCommon StockSEC:0001493152-25-025277:1
Canonical exit: 20 Jul 2025 (T+90)
45,000 shares0Common StockSEC:0001493152-25-025277:9
200,000 shares0Common StockSEC:0001493152-25-025279:20
45,000 shares0Common StockSEC:0001493152-25-025279:21
1,250 shares@ US$1.030.0% of flowCommon StockSEC:0001493152-25-025279:19
Canonical exit: 24 Dec 2025 (T+90)
45,000 shares0Common StockSEC:0001493152-25-025274:8
25 of 127 declarations
About OneMedNet Corp
OneMedNet Corp is a company listed on the XNAS market, specializing in healthcare data management solutions. It focuses on improving access to and analysis of medical information.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
